# 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer

> **NCT04227249** · — · NOT_YET_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 153 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** no lymph node dissection

## Key facts

- **NCT ID:** NCT04227249
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2020-04
- **Primary completion:** 2025-03
- **Final completion:** 2027-03
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04227249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04227249, "3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04227249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*